Literature DB >> 21093919

Studies of the H60a locus in C57BL/6 and 129/Sv mouse strains identify the H60a 3'UTR as a regulator of H60a expression.

Hui Zhang1, Chanae Hardamon, Bright Sagoe, Jennifer Ngolab, Jack D Bui.   

Abstract

The minor histocompatibility antigen 60 (H60a) is expressed in BALB/C and 129/Sv but not in C57BL/6 strains of mice. We recently found that IFNγ down-regulates H60a, but the mechanism of regulation is not known. To better understand the regulation of H60a, we examined the genomic locus of H60a in 129/Sv and C57BL/6 strains. We found that the upstream regulatory region of H60a was present and functional in both strains. Interestingly, IFNγ can down-regulate H60a transcripts in cell lines from 129/Sv but not C57BL/6 strains of mice, suggesting that IFNγ-dependent regulation of H60a proceeds through cis elements other than the conserved promoter region. We determined that the regulation of H60a by IFNγ proceeds through the 3'UTR of H60a, which is present in 129/Sv, but not C57BL/6 cells. We also found that the H60a 3'UTR and microRNAs can contribute to the level of constitutive expression of H60a in tumor cell lines. We conclude that in 129/Sv strain mice, H60a can be regulated by its 3'UTR through IFNγ and unknown microRNAs. Since H60a mediates NK cell target recognition, our studies identify a cis element that can regulate virus and tumor surveillance.
Copyright © 2010 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21093919      PMCID: PMC3030190          DOI: 10.1016/j.molimm.2010.10.015

Source DB:  PubMed          Journal:  Mol Immunol        ISSN: 0161-5890            Impact factor:   4.407


  30 in total

1.  IFN-dependent down-regulation of the NKG2D ligand H60 on tumors.

Authors:  Jack D Bui; Leonidas N Carayannopoulos; Lewis L Lanier; Wayne M Yokoyama; Robert D Schreiber
Journal:  J Immunol       Date:  2006-01-15       Impact factor: 5.422

2.  Broad tumor-associated expression and recognition by tumor-derived gamma delta T cells of MICA and MICB.

Authors:  V Groh; R Rhinehart; H Secrist; S Bauer; K H Grabstein; T Spies
Journal:  Proc Natl Acad Sci U S A       Date:  1999-06-08       Impact factor: 11.205

3.  Comparative analysis of regulatory and effector T cells in progressively growing versus rejecting tumors of similar origins.

Authors:  Jack D Bui; Ravindra Uppaluri; Chyi-Song Hsieh; Robert D Schreiber
Journal:  Cancer Res       Date:  2006-07-15       Impact factor: 12.701

4.  Two novel NKG2D ligands of the mouse H60 family with differential expression patterns and binding affinities to NKG2D.

Authors:  Akio Takada; Shigeru Yoshida; Mizuho Kajikawa; Yukiko Miyatake; Utano Tomaru; Masaharu Sakai; Hitoshi Chiba; Katsumi Maenaka; Daisuke Kohda; Kazunori Fugo; Masanori Kasahara
Journal:  J Immunol       Date:  2008-02-01       Impact factor: 5.422

5.  Interferon modulation of cellular microRNAs as an antiviral mechanism.

Authors:  Irene M Pedersen; Guofeng Cheng; Stefan Wieland; Stefano Volinia; Carlo M Croce; Francis V Chisari; Michael David
Journal:  Nature       Date:  2007-10-18       Impact factor: 49.962

6.  The molecular and functional characterization of a dominant minor H antigen, H60.

Authors:  S Malarkannan; P P Shih; P A Eden; T Horng; A R Zuberi; G Christianson; D Roopenian; N Shastri
Journal:  J Immunol       Date:  1998-10-01       Impact factor: 5.422

7.  NKG2D-deficient mice are defective in tumor surveillance in models of spontaneous malignancy.

Authors:  Nadia Guerra; Ying Xim Tan; Nathalie T Joncker; Augustine Choy; Fermin Gallardo; Na Xiong; Susan Knoblaugh; Dragana Cado; Norman M Greenberg; Norman R Greenberg; David H Raulet
Journal:  Immunity       Date:  2008-04       Impact factor: 31.745

8.  Molecular regulation of MHC class I chain-related protein A expression after HDAC-inhibitor treatment of Jurkat T cells.

Authors:  Lars Andresen; Helle Jensen; Marianne T Pedersen; Karen A Hansen; Søren Skov
Journal:  J Immunol       Date:  2007-12-15       Impact factor: 5.422

9.  NKG2D function protects the host from tumor initiation.

Authors:  Mark J Smyth; Jeremy Swann; Erika Cretney; Nadeen Zerafa; Wayne M Yokoyama; Yoshihiro Hayakawa
Journal:  J Exp Med       Date:  2005-08-29       Impact factor: 14.307

Review 10.  Regulation of ligands for the activating receptor NKG2D.

Authors:  Anita R Mistry; Chris A O'Callaghan
Journal:  Immunology       Date:  2007-08       Impact factor: 7.397

View more
  9 in total

1.  T Cells Engineered With Chimeric Antigen Receptors Targeting NKG2D Ligands Display Lethal Toxicity in Mice.

Authors:  Heather VanSeggelen; Joanne A Hammill; Anna Dvorkin-Gheva; Daniela G M Tantalo; Jacek M Kwiecien; Galina F Denisova; Brian Rabinovich; Yonghong Wan; Jonathan L Bramson
Journal:  Mol Ther       Date:  2015-06-30       Impact factor: 11.454

2.  Cancer immunoediting of the NK group 2D ligand H60a.

Authors:  Timothy O'Sullivan; Gavin P Dunn; Daphne Y Lacoursiere; Robert D Schreiber; Jack D Bui
Journal:  J Immunol       Date:  2011-08-29       Impact factor: 5.422

3.  Studies on the antigenicity of the NKG2D ligand H60a in tumour cells.

Authors:  Deepak Yadav; Jennifer Ngolab; Natalie Dang; Jack D Bui
Journal:  Immunology       Date:  2011-03-25       Impact factor: 7.397

Review 4.  Immunogenetics of the NKG2D ligand gene family.

Authors:  Masanori Kasahara; Shigeru Yoshida
Journal:  Immunogenetics       Date:  2012-07-29       Impact factor: 2.846

5.  The nuclear factor-κB pathway down-regulates expression of the NKG2D ligand H60a in vitro: implications for use of nuclear factor-κB inhibitors in cancer therapy.

Authors:  Carlos Peinado; Xi Kang; Chanae Hardamon; Sumit Arora; Stephen Mah; Hui Zhang; Jennifer Ngolab; Jack D Bui
Journal:  Immunology       Date:  2013-06       Impact factor: 7.397

6.  Sixteen diverse laboratory mouse reference genomes define strain-specific haplotypes and novel functional loci.

Authors:  Jingtao Lilue; Anthony G Doran; Ian T Fiddes; Monica Abrudan; Joel Armstrong; Ruth Bennett; William Chow; Joanna Collins; Stephan Collins; Anne Czechanski; Petr Danecek; Mark Diekhans; Dirk-Dominik Dolle; Matt Dunn; Richard Durbin; Dent Earl; Anne Ferguson-Smith; Paul Flicek; Jonathan Flint; Adam Frankish; Beiyuan Fu; Mark Gerstein; James Gilbert; Leo Goodstadt; Jennifer Harrow; Kerstin Howe; Ximena Ibarra-Soria; Mikhail Kolmogorov; Chris J Lelliott; Darren W Logan; Jane Loveland; Clayton E Mathews; Richard Mott; Paul Muir; Stefanie Nachtweide; Fabio C P Navarro; Duncan T Odom; Naomi Park; Sarah Pelan; Son K Pham; Mike Quail; Laura Reinholdt; Lars Romoth; Lesley Shirley; Cristina Sisu; Marcela Sjoberg-Herrera; Mario Stanke; Charles Steward; Mark Thomas; Glen Threadgold; David Thybert; James Torrance; Kim Wong; Jonathan Wood; Binnaz Yalcin; Fengtang Yang; David J Adams; Benedict Paten; Thomas M Keane
Journal:  Nat Genet       Date:  2018-10-01       Impact factor: 41.307

Review 7.  H60: A Unique Murine Hematopoietic Cell-Restricted Minor Histocompatibility Antigen for Graft-versus-Leukemia Effect.

Authors:  Eun Young Choi; Kyungho Choi; Giri Nam; Woojin Kim; Minho Chung
Journal:  Front Immunol       Date:  2020-06-10       Impact factor: 7.561

8.  ASK1 suppresses NK cell-mediated intravascular tumor cell clearance in lung metastasis.

Authors:  Makoto Fujimoto; Miki Kamiyama; Kosuke Fuse; Hiroki Ryuno; Takeru Odawara; Natsuki Furukawa; Yasuhiro Yoshimatsu; Tetsuro Watabe; Michaela Prchal-Murphy; Veronika Sexl; Hideaki Tahara; Yoshihiro Hayakawa; Takehiro Sato; Kohsuke Takeda; Isao Naguro; Hidenori Ichijo
Journal:  Cancer Sci       Date:  2021-03-06       Impact factor: 6.716

9.  Epigenetic regulation of NKG2D ligands is involved in exacerbated atherosclerosis development in Sirt6 heterozygous mice.

Authors:  Zhu-Qin Zhang; Si-Chong Ren; Ying Tan; Zuo-Zhi Li; Xiaoqiang Tang; Ting-Ting Wang; De-Long Hao; Xiang Zhao; Hou-Zao Chen; De-Pei Liu
Journal:  Sci Rep       Date:  2016-04-05       Impact factor: 4.379

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.